Sudhir Agrawal, D.Phil.

Sudhir Agrawal, D. Phil., FRSC, is the founder and President of ARNAY Sciences. He also serves as an Affiliate Professor in the Department of Medicine at UMass Chan Medical School. Over the last three decades, his research has focused on discovering and developing RNA therapeutics, including antisense and immunotherapy. He has published over 300 research papers and is listed as a co-inventor of more than 400 patents worldwide. He has edited four books on oligonucleotides and antisense technology, including a recent book on ‘Advances in Nucleic Acid Therapeutics’ by The Royal Society of Chemistry. He is currently serving as a member of the Scientific Advisory Board of several biotechnology companies.